Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation

Core-binding factor AML can evolve from good-risk disease into aggressive disease through the gain of additional genomic aberrations. In this unique case, an AML patient died of hypereosinophilic syndrome with solid organ infiltration of differentiated eosinophils.